 | |
| Names | |
|---|---|
| IUPAC name (RS)-3,6,7,7a-Tetrahydro-1H-pyrrolo[1,2-a]imidazole-2,5-dione | |
| Identifiers | |
3D model (JSmol) | |
| ChEMBL | |
| ChemSpider |
|
| UNII | |
| |
| |
| Properties | |
| C6H8N2O2 | |
| Molar mass | 140.142 g·mol−1 |
| Pharmacology | |
| Legal status | |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
Dimiracetam is anootropic drug of theracetam family,[1] derivatives of which may have application in the treatment ofneuropathic pain.[2]
Dimiracetam is a schedule 4 substance in Australia under thePoisons Standard (February 2020).[3] A schedule 4 substance is classified as "Prescription Only Medicine, or Prescription Animal Remedy – Substances, the use or supply of which should be by or on the order of persons permitted by State or Territory legislation to prescribe and should be available from a pharmacist on prescription."[3]
 | Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |
